Chemoinformaics analysis of 2,7,7-Trimethylbicyclo[3.1.1]hept-1(6)-en-2-ol
| Molecular Weight | 152.237 | nRot | 0 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 24 |
| Exact Molecular Weight | 152.12 | nRing | 3 |
| Solubility: LogS | -3.374 | nHRing | 0 |
| Solubility: LogP | 4.088 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 28.1707 |
| nHD | 1 | BPOL | 16.0513 |
| QED | 0.185 |
| Synth | 4.054 |
| Natural Product Likeliness | 2.039 |
| NR-PPAR-gamma | 0.854 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.123 |
| Pgp-sub | 0.038 |
| HIA | 0.08 |
| CACO-2 | -6.283 |
| MDCK | 0.00000698 |
| BBB | 0.002 |
| PPB | 0.957021 |
| VDSS | 0.386 |
| FU | 0.0363129 |
| CYP1A2-inh | 0.043 |
| CYP1A2-sub | 0.867 |
| CYP2c19-inh | 0.027 |
| CYP2c19-sub | 0.058 |
| CYP2c9-inh | 0.591 |
| CYP2c9-sub | 0.631 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.206 |
| CYP3a4-inh | 0.089 |
| CYP3a4-sub | 0.553 |
| CL | 9.442 |
| T12 | 0.648 |
| hERG | 0.047 |
| Ames | 0.092 |
| ROA | 0.185 |
| SkinSen | 0.958 |
| Carcinogencity | 0.025 |
| EI | 0.897 |
| Respiratory | 0.036 |
| NR-Aromatase | 0.86 |
| Antiviral | No |
| Prediction | 0.920852 |